The molecular perspective: VEGF and angiogenesis.
Goodsell
David S
DS
The Scripps Research Institute, Department of Molecular Biology, La Jolla, California 92037, USA. goodsell@scripps.edu
D000906:Antibodies / Q000378:metabolism / Q000627:therapeutic use; D016228:Endothelial Growth Factors / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D008222:Lymphokines / Q000276:immunology / Q000378:metabolism / Q000502:physiology*; D008958:Models, Molecular; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D011485:Protein Binding / Q000276:immunology / Q000502:physiology; D040262:Receptors, Vascular Endothelial Growth Factor / Q000276:immunology / Q000378:metabolism / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000906:Antibodies; D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D040262:Receptors, Vascular Endothelial Growth Factor